Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Post-transplantation lymphoproliferative disorder in pediatric patient.

Fernandes PM, Azeka E, Odoni V, Junqueira JJ, Bento GP, Aiello V, Barbero-Marcial M.

Arq Bras Cardiol. 2006 Oct;87(4):e108-11. English, Portuguese.

2.

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.

Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.

Pediatr Transplant. 2009 Feb;13(1):54-62. doi: 10.1111/j.1399-3046.2008.00969.x. Epub 2008 Jun 1.

PMID:
18518912
3.

Successful treatment with rituximab of lymphoproliferative disorder in a child after cardiac transplantation.

Herman J, Vandenberghe P, van den Heuvel I, Van Cleemput J, Winnepenninckx V, Van Damme-Lombaerts R.

J Heart Lung Transplant. 2002 Dec;21(12):1304-9.

PMID:
12490276
4.

Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.

Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.

J Pediatr Surg. 2008 Dec;43(12):2174-7. doi: 10.1016/j.jpedsurg.2008.08.044.

PMID:
19040929
5.
6.

Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients.

Dayton JD, Richmond ME, Weintraub RG, Shipp AT, Orjuela M, Addonizio LJ.

J Heart Lung Transplant. 2011 Apr;30(4):420-5. doi: 10.1016/j.healun.2010.10.004. Epub 2010 Dec 13.

PMID:
21147001
7.

Cyclosphosphamide/prednisone for combination immunosuppression and therapy of lymphoproliferative disease.

Balfour IC, Wall D, Luisiri A, Sotelo C, Gross TG.

J Heart Lung Transplant. 1999 May;18(5):492-5.

PMID:
10363695
8.

Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.

Cullis B, D'Souza R, McCullagh P, Harries S, Nicholls A, Lee R, Bingham C.

Am J Kidney Dis. 2006 May;47(5):e67-72.

PMID:
16632009
9.

Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.

Keay S, Oldach D, Wiland A, Klassen D, Schweitzer E, Abruzzo LV, Kumar D, Bartlett S.

Clin Infect Dis. 1998 Mar;26(3):596-600.

PMID:
9524829
10.

Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.

Khalpey Z, Miller DV, Schmitto JD, Kushwaha SS.

Transplant Proc. 2011 Jun;43(5):1893-9. doi: 10.1016/j.transproceed.2011.03.033.

PMID:
21693296
11.

Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.

Elidemir O, Kancherla BS, Schecter MG, McKenzie ED, Morales DL, Heinle JS, Mallory GB.

Pediatr Transplant. 2009 Aug;13(5):606-10. doi: 10.1111/j.1399-3046.2008.01085.x. Epub 2008 Nov 9.

PMID:
19017289
12.

Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.

Patel H, Vogl DT, Aqui N, Shaked A, Olthoff K, Markmann J, Reddy R, Stadtmauer EA, Schuster S, Tsai DE.

Leuk Lymphoma. 2007 May;48(5):885-91.

PMID:
17487731
13.

Ocular involvement in patients with posttransplant lymphoproliferative disorder.

Cho AS, Holland GN, Glasgow BJ, Isenberg SJ, George BL, McDiarmid SV.

Arch Ophthalmol. 2001 Feb;119(2):183-9.

PMID:
11176978
14.

Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.

Kaczmarek I, Beiras-Fernandez A, Sadoni S, Bengel D, Deutsch MA, Meiser B, Reichart B.

Exp Clin Transplant. 2005 Dec;3(2):381-4.

15.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
16.

CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.

Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.

J Clin Oncol. 2007 Nov 1;25(31):4902-8.

PMID:
17971586
17.

Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.

Aversa SM, Stragliotto S, Marino D, Calabrese F, Rigotti P, Marchini F, Gambino A, Feltrin G, Boso C, Canova F, Soldà C, Mazzarotto R, Burra P.

Acta Haematol. 2008;120(1):36-46. doi: 10.1159/000155234. Epub 2008 Sep 16.

PMID:
18797163
18.

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.

J Clin Oncol. 2009 Jul 10;27(20):3354-62. doi: 10.1200/JCO.2008.20.0857. Epub 2009 May 18.

PMID:
19451438
19.

Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.

Lai YC, Ni YH, Jou ST, Ho MC, Wu JF, Chen HL, Hu RH, Jeng YM, Chang MH, Lee PH.

Pediatr Transplant. 2006 May;10(3):390-4.

PMID:
16677368
20.

Cecal perforation as a rare initial manifestation of post-transplant lymphoproliferative disorder after cardiac transplantation.

Hoefer D, Bonatti H, Poelzl G, Mark W, Ott H, Antretter H.

J Heart Lung Transplant. 2005 Apr;24(4):505-6. No abstract available.

PMID:
15797759

Supplemental Content

Support Center